pancreatic ductal adenocarcinoma

Photo of a man looking up at the sky, with the green leaves and branches of a large tree behind him.
Mayo Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer

The presence of a specific genetic mutation — KRAS circulating tumor DNA (ctDNA) — strongly indicates a higher risk of spread and worse survival rates for people with pancreatic cancer.

An older man reading from a folder in front of a laptop
PET/MRI biomarkers guide personalized treatment for people with pancreatic cancer, study finds

A recent study provides support for Mayo Clinic's use of positron emission tomography (PET) to guide pancreatic cancer treatment decisions.